Article List

WPRIM Management System> DCMS> Chinese journal of integrative medicine> 2014> 20> 5

Volume: 20 Issue: 5

1. Traditional East Asian medicine: how to understand and approach diagnostic findings and patterns in a modern scientific framework?	Page:336—340
2. Designing clinical studies that take into account traditional East Asian medicine's systems and methods - with focus on pattern identification.	Page:332—335
3. Insights of Chinese medicine syndrome study: from current status to future prospects.	Page:326—331
4. Effects of Danshen Injection () on inhibiting proliferation and inducing apoptosis through down-regulation of mutant JAK2 gene and its protein phosphorylation in human erythroid leukemic cells.	Page:381—386
5. Effects of royal jelly supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: a randomized clinical trial.	Page:347—352
6. Effects of acupuncture at Baihui (DU20) and Zusanli (ST36) on the expression of heat shock protein 70 and tumor necrosis factor α in the peripheral serum of cerebral ischemia-reperfusion-injured rats.	Page:369—374
7. Arsenic disulfide induced apoptosis and concurrently promoted erythroid differentiation in cytokine-dependent myelodysplastic syndrome-progressed leukemia cell line F-36p with complex karyotype including monosomy 7.	Page:387—393
8. Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease.	Page:341—346
9. Zhuanggu Jianxi Decoction () limits interleukin-1 β-induced degeneration chondrocytes via the caveolin-p38 MAPK signal pathway.	Page:353—359
10. Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: a Chinese medicine hospital versus a general hospital.	Page:375—380
11. Syndrome classification based on manifold ranking for viral hepatitis.	Page:394—399
12. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways.	Page:360—368